|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：B115650 |
| 產(chǎn)品名稱：Balicatib |
| 產(chǎn)品CAS：354813-19-7 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
B115650 |
| 名稱: |
Balicatib |
| 別名: |
N-[1-(Cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide; N-[1-[[(Cyanomethyl)amino]carbonyl]cyclohexyl]-4-(4-propyl-1-piperazinyl)benzamide; |
| CAS號(hào): |
354813-19-7 |
| 分子式: |
C??H??N?O? |
| 分子量: |
411.54 |
| 類(lèi)別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Balicatib is a potent inhibitor of Cathepsin K (Cat K), a lysosomal cysteine protease, for the treatment of osteoporosis. |
| 文獻(xiàn) |
|
|
|
|
?您的位置：
